Phone:| Tech Support:| E-mail:
Home > Products > Small molecule > Metabolism > Atorvastatin hemicalcium salt

Atorvastatin hemicalcium salt

Product #: TL0047
Image SKU-Pack Size Stock Price($) Quantity

Documents

Details

l  General Information

Product Name

Atorvastatin hemicalcium salt

General description

Atorvastatin hemicalcium salt is the calcium salt of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin is a HMG-CoA Reductase Inhibitor. The mechanism of action of atorvastatin is as a   Hydroxymethylglutaryl-CoA Reductase Inhibitor.

Synonym

(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5 dihydroxyheptanoate, hemicalcium salt

Purity

≥98%(HPLC)

CAS   Number

134523-03-8

Formula

C66H68CaF2N4O10

Molecular   Weight

1155.363

Suitability

BioReagent, suitable for cell culture, etc.

l  Physical and Chemical Information

Appearance

White or Off-white solid

Solubility(25℃)

DMSO

≥50mg/mL

Ethanol

Insoluble

Water

Insoluble

l  Biological Information

Biochem/Physiol   Actions

Atorvastatin Calcium is the calcium salt of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent increases the number of LDL receptors on hepatic cell surfaces, enhancing the uptake and catabolism of LDL and reducing LDL production and the number of LDL particles, and lowers plasma cholesterol and lipoprotein levels. Like other statins, atorvastatin may also display direct antineoplastic activity, possibly by inhibiting farnesylation and geranylgeranylation of proteins such as small GTP-binding proteins, which may result in the arrest of cells in the G1 phase of the cell cycle. This agent may also sensitize tumor cells to cyctostatic drugs, possibly through the mTOR-dependent inhibition of Akt phosphorylation.

Application

1.      Hydroxymethylglutaryl-CoA Reductase Inhibitors

Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.

2.      Anticholesteremic Agents

Substances used to lower plasma cholesterol levels.

l  Packaging & Storage

Packaging

250mg; 1g

Storage temp.

0-5℃

l  Precautions and Disclaimer

This   product is for R&D use only, not for drug, household, or other uses.

l  References

1.    http://www.drugbank.ca

2.    https://ncit.nci.nih.gov

3.    https://www.ncbi.nlm.nih.gov

 


天问科技